A valuable CRO offers experiential wisdom along with forward thinking and flexibility. When medicine advances and long-held concepts evolve, you want to be working with specialists who are versed in the new approaches and already meeting fresh, related challenges. Those specialists are at Worldwide Clinical Trials.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs — in the best possible way. From Bioanalytical Sciences through Phase IIa trials, our Early Phase Services include a 300-bed clinical site in San Antonio, Texas that is GCP/ICH compliant. Specimens are seamlessly transferred internally, or to a lab of your choice, for sample bioanalysis. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs — in the best possible way. From Bioanalytical Sciences through Phase IIa trials, our Early Phase Services include a 300-bed clinical site in San Antonio, Texas that is GCP/ICH compliant. Specimens are seamlessly transferred internally, or to a lab of your choice, for sample bioanalysis. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs. From Early Phase to Phase II and IV clinical trials, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we leverage our global footprint and operational excellence to execute predictable, successful studies. We never compromise on science. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs. From Early Phase to Phase II and IV clinical trials, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we leverage our global footprint and operational excellence to execute predictable, successful studies. We never compromise on science. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.
Our tradition of excellence is centered on Alzheimer’s Disease, with our unparalleled experience in this indication (including related dementias) allowing us not only to understand the complexities associated with evaluating patients with various phenotypes, but also to implement specific design features through the use of strategies to mitigate the risks and challenges in the Alzheimer’s field.
Recent understandings have both enlightened and complicated oncology clinical research. Key among them is the heterogeneity of tumors at the same primary site. The ensuing necessity for companion diagnostics to identify which patients will benefit from a targeted therapy and for rapid identification of molecules that can sidestep acquired resistance, plus progress in immunologic- and vaccine-based treatments, have increased the complexity of drug development. At Worldwide Clinical Trials, our core oncology expertise means your trial starts from a favorable, advanced position. Our commitment to your study objectives and our ability to proactively identify and overcome operational challenges mitigate your risk.
Recent understandings have both enlightened and complicated oncology clinical research. Key among them is the heterogeneity of tumors at the same primary site. The ensuing necessity for companion diagnostics to identify which patients will benefit from a targeted therapy and for rapid identification of molecules that can sidestep acquired resistance, plus progress in immunologic- and vaccine-based treatments, have increased the complexity of drug development. At Worldwide Clinical Trials, our core oncology expertise means your trial starts from a favorable, advanced position. Our commitment to your study objectives and our ability to proactively identify and overcome operational challenges mitigate your risk.
Recording, managing, reviewing and approving required Trip Checklists and Monitoring Action Items (MAIs) can be challenging. The Monitoring Trip Checklists tool allows monitors and clinical managers to easily do all of this in a centralized location within iMedNet.
Manually reviewing and approving site payments is time consuming, costly and prone to errors. The iMedNet Payment Manager quickly automates this process so study administrators can easily apply site specific study budgets, view and approve eligible payments, and access a complete transaction history.
|
|
|
|
|
|
|
|
|